Username Password
S&P 500: 1,342.64 Change: +0.17%
Aldecoa
P&P Score: 0.37 | Points: -301.40 | Accuracy: 32.47 | Average Pick Score: -16.91   Annual Return: N/A  
Open
 
Closed
 
All
 
Commentary
BUY: MYRIAD GENETICS INC. (MYGN) Rating: 2
Start Price: $41.80
Points: -105.64
Created: 02/04/2009
Not the type of stock I'd usually invest in, but as a shareholder of Panacos I know that Bevirimat works very well in reducing HIV viral load and the side effects are equivalent to placebo. Panacos knew that it didn't have the money to market this product and decided to sell it to Myriad Genetics for $7 million. Myriad should benefit from this for years to come.

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

register
Sponsored Links

Free Options Trader Guide